Folasade R. Olayoku, Nicolette J. D. Verhoog, & Ann Louw. (2023). Cyclopia extracts act as selective estrogen receptor subtype downregulators in estrogen receptor positive breast cancer cell lines: Comparison to standard of care breast cancer endocrine therapies and a selective estrogen receptor agonist and antagonist. Frontiers Media S.A..
Chicago Style (17th ed.) CitationFolasade R. Olayoku, Nicolette J. D. Verhoog, and Ann Louw. Cyclopia Extracts Act as Selective Estrogen Receptor Subtype Downregulators in Estrogen Receptor Positive Breast Cancer Cell Lines: Comparison to Standard of Care Breast Cancer Endocrine Therapies and a Selective Estrogen Receptor Agonist and Antagonist. Frontiers Media S.A., 2023.
MLA (9th ed.) CitationFolasade R. Olayoku, et al. Cyclopia Extracts Act as Selective Estrogen Receptor Subtype Downregulators in Estrogen Receptor Positive Breast Cancer Cell Lines: Comparison to Standard of Care Breast Cancer Endocrine Therapies and a Selective Estrogen Receptor Agonist and Antagonist. Frontiers Media S.A., 2023.